Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of SP and SP+PQ IPT in Schoolchildren
NCT01722539Phase 3Completed
- Sponsor
- University of Antwerp
- Start
- Nov 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sulfadoxine + pyrimethamine and piperaquine in malaria (3 arms), sponsored by University of Antwerp. Primary endpoint: Hemoglobin change at Month 12. Started Nov 2012; status: completed.
02
Drugs
sulfadoxine + pyrimethaminepiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01722539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722539.